Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local beta-radiation emission targets tumor tissues by delivering therapeutic doses of ionizing radiation precisely within malignant growths, minimizing collateral damage. This is achieved through the selection of appropriate radioisotopes, delivery methods (systemic or intratumoral), and molecular targeting strategies that enhance selectivity for tumor cells. The beta particles emitted cause localized DNA damage, leading to cell death.
Localized emission of beta particles causing DNA damage and cell death in tumor cells and surrounding tissue.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Tissue via Local Beta-Radiation Emission.